|
MPHOSPH9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.407020E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.104600E-01 |
| Normal-vs-Stage2 |
1.968780E-01 |
| Normal-vs-Stage3 |
1.537430E-01 |
| Normal-vs-Stage4 |
5.352200E-01 |
| Stage1-vs-Stage2 |
1.086370E-01 |
| Stage1-vs-Stage3 |
9.244200E-02 |
| Stage1-vs-Stage4 |
3.737600E-01 |
| Stage2-vs-Stage3 |
9.157600E-01 |
| Stage2-vs-Stage4 |
8.210600E-01 |
| Stage3-vs-Stage4 |
8.697400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.996010E-01 |
| Normal-vs-AfricanAmerican |
5.092800E-01 |
| Normal-vs-Asian |
9.035400E-01 |
| Caucasian-vs-AfricanAmerican |
7.693200E-01 |
| Caucasian-vs-Asian |
7.216000E-01 |
| AfricanAmerican-vs-Asian |
7.456600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.446400E-01 |
| Normal-vs-Female |
1.315110E-03 |
| Male-vs-Female |
9.015000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.655200E-01 |
| Normal-vs-Extreme_Weight |
9.493900E-02 |
| Normal-vs-Obese |
7.038500E-02 |
| Normal-vs-Extreme_Obese |
8.536400E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.191400E-01 |
| Normal_Weight-vs-Obese |
3.013000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.817600E-01 |
| Extreme_Weight-vs-Obese |
5.835100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.661800E-01 |
| Obese-vs-Extreme_Obese |
5.518000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.884640E-01 |
| Normal-vs-Age(41-60Yrs) |
4.493600E-02 |
| Normal-vs-Age(61-80Yrs) |
7.287800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.706000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.595800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.033400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.432650E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.640620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.789200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.026400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.229400E-01 |
| Normal-VS-Type2 PRCC |
6.268000E-02 |
| Normal-VS-KIRP CIMP |
4.146800E-01 |
| Normal-VS-Unclassified PRCC |
4.828000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
6.322100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.139600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.702400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.954200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.038600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.689600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.031200E-01 |
| Normal-vs-N1 |
4.587900E-02 |
| Normal-vs-N2 |
5.587600E-01 |
| N0-vs-N1 |
3.031900E-02 |
| N0-vs-N2 |
3.718600E-01 |
| N1-vs-N2 |
6.795600E-01 |
|
|
